TW215088B - - Google Patents

Download PDF

Info

Publication number
TW215088B
TW215088B TW079110759A TW79110759A TW215088B TW 215088 B TW215088 B TW 215088B TW 079110759 A TW079110759 A TW 079110759A TW 79110759 A TW79110759 A TW 79110759A TW 215088 B TW215088 B TW 215088B
Authority
TW
Taiwan
Prior art keywords
formula
group
alkyl
methyl
phenyl
Prior art date
Application number
TW079110759A
Other languages
English (en)
Chinese (zh)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Application granted granted Critical
Publication of TW215088B publication Critical patent/TW215088B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Insulating Materials (AREA)
  • Vibration Prevention Devices (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
TW079110759A 1989-12-22 1990-12-21 TW215088B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898929022A GB8929022D0 (en) 1989-12-22 1989-12-22 Diazine derivatives
GB909025810A GB9025810D0 (en) 1989-12-22 1990-11-28 Diazine derivatives

Publications (1)

Publication Number Publication Date
TW215088B true TW215088B (cg-RX-API-DMAC7.html) 1993-10-21

Family

ID=10668392

Family Applications (1)

Application Number Title Priority Date Filing Date
TW079110759A TW215088B (cg-RX-API-DMAC7.html) 1989-12-22 1990-12-21

Country Status (21)

Country Link
US (1) US5252567A (cg-RX-API-DMAC7.html)
EP (1) EP0434341B1 (cg-RX-API-DMAC7.html)
JP (1) JPH03291277A (cg-RX-API-DMAC7.html)
KR (1) KR910011838A (cg-RX-API-DMAC7.html)
AT (1) ATE122672T1 (cg-RX-API-DMAC7.html)
AU (1) AU641960B2 (cg-RX-API-DMAC7.html)
CA (1) CA2032743A1 (cg-RX-API-DMAC7.html)
DE (1) DE69019489T2 (cg-RX-API-DMAC7.html)
DK (1) DK0434341T3 (cg-RX-API-DMAC7.html)
ES (1) ES2072993T3 (cg-RX-API-DMAC7.html)
FI (1) FI906306A7 (cg-RX-API-DMAC7.html)
GB (2) GB8929022D0 (cg-RX-API-DMAC7.html)
HU (1) HU207511B (cg-RX-API-DMAC7.html)
IE (1) IE904391A1 (cg-RX-API-DMAC7.html)
IL (1) IL96609A0 (cg-RX-API-DMAC7.html)
NO (1) NO905378L (cg-RX-API-DMAC7.html)
NZ (1) NZ236417A (cg-RX-API-DMAC7.html)
PT (1) PT96315B (cg-RX-API-DMAC7.html)
TW (1) TW215088B (cg-RX-API-DMAC7.html)
ZA (1) ZA909852B (cg-RX-API-DMAC7.html)
ZW (1) ZW19290A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
EP1654249A1 (en) * 2003-08-07 2006-05-10 Pharmacia & Upjohn Company LLC Anthelmintic and insecticide pyrimidine derivatives
US7741976B2 (en) * 2005-12-16 2010-06-22 Hunt Power, L.P. Server and method for processing meter data into a common format
MY195016A (en) 2014-08-04 2023-01-03 Nuevolution As Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases
AU2020405446A1 (en) 2019-12-20 2022-05-26 Nuevolution A/S Compounds active towards nuclear receptors
BR112022012205A2 (pt) 2019-12-20 2022-09-13 Nuevolution As Compostos ativos para receptores nucleares
CA3174252A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
JP7713954B2 (ja) 2020-03-31 2025-07-28 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB815833A (en) * 1956-09-26 1959-07-01 Boots Pure Drug Co Ltd Phenanthridine compounds
BE492034A (cg-RX-API-DMAC7.html) * 1948-11-05
DE1445740A1 (de) * 1963-09-04 1968-11-28 Bayer Ag Verfahren zur Herstellung von Bispyrimidinium-Verbindungen
US4339453A (en) * 1979-07-23 1982-07-13 Merck & Co., Inc. Antimicrobial aminopyrimidinium salts
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
FR2524467A1 (fr) * 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4503050A (en) * 1983-06-02 1985-03-05 Riker Laboratories, Inc. Substituted imidazo[1,2-c]pyrimidines
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
WO1987001706A2 (en) * 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
DE3703633A1 (de) * 1986-02-14 1987-08-20 Sandoz Ag Purin-derivate, ihre herstellung und sie enthaltende arzneimittel
US4729995A (en) * 1986-04-21 1988-03-08 Toyo Boseki Kabushiki Kaisha Pyrimidine 2,4-dioxamate compounds and pharmaceutical compositions
DE3629563A1 (de) * 1986-08-02 1988-02-04 Mildenberger & Willing Verpack Tragbarer verpackungsbeutel aus kunststoffolie und verfahren zu dessen herstellung
DE3639563A1 (de) * 1986-11-20 1988-06-01 Basf Ag N-arylsulfonyl-n'-pyrimidyl(triazinyl) -harnstoffe
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DK0434341T3 (da) 1995-10-09
US5252567A (en) 1993-10-12
ZW19290A1 (en) 1991-09-18
ATE122672T1 (de) 1995-06-15
HUT56087A (en) 1991-07-29
HU207511B (en) 1993-04-28
FI906306A0 (fi) 1990-12-20
EP0434341B1 (en) 1995-05-17
KR910011838A (ko) 1991-08-07
PT96315B (pt) 1998-06-30
GB8929022D0 (en) 1990-02-28
DE69019489D1 (de) 1995-06-22
ES2072993T3 (es) 1995-08-01
IL96609A0 (en) 1991-09-16
ZA909852B (en) 1991-10-30
CA2032743A1 (en) 1991-06-23
NO905378L (no) 1991-06-24
JPH03291277A (ja) 1991-12-20
AU6791490A (en) 1991-06-27
EP0434341A1 (en) 1991-06-26
NO905378D0 (no) 1990-12-12
FI906306A7 (fi) 1991-06-23
IE904391A1 (en) 1991-07-03
GB9025810D0 (en) 1991-01-09
DE69019489T2 (de) 1995-09-21
PT96315A (pt) 1991-09-30
NZ236417A (en) 1994-04-27
AU641960B2 (en) 1993-10-07
HU908115D0 (en) 1991-06-28

Similar Documents

Publication Publication Date Title
US6653320B2 (en) Imidazopyridine derivatives
KR100830859B1 (ko) 이미다조피리딘 유도체 및 이를 함유하는 의약 조성물
TWI305204B (en) Lactam compounds for inhibiting ß-amyloid p eptide release and/or its synthesis and pharmaceutical compositions comprising the same
TWI279402B (en) Spiro compounds having NPY antagonistic activities and agents containing the same
JP4854970B2 (ja) 療法において有用なトロパン誘導体
CA2455296C (en) 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors
TW296383B (cg-RX-API-DMAC7.html)
TWI313264B (en) Triamide-substituted heterobicyclic compounds
CN105764905B (zh) 新的八氢-环丁二烯并[1,2-c;3,4-c’]二吡咯-2基
JP2001518504A (ja) 5ht4作動薬および拮抗薬
JPS61236764A (ja) 新規なインドール誘導体およびその酸付加塩ならびにそれらを含有する精神病治療剤
TW200410688A (en) Therapeutics for diseases from vasoconstriction or vasodilatation
JP2008501628A (ja) インドール誘導体およびがんの治療用途
TW200804390A (en) Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
SK280907B6 (sk) Deriváty tetrahydrokarbazolu, spôsob ich prípravy a farmaceutický prípravok s ich obsahom
TW200831476A (en) Cyclic sulfonamide derivatives and methods of their use
HUP0104280A2 (hu) Dopamin D3 receptorok modulátoraiként felhasználható tetrahidrobenzazepin-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények
TW201041856A (en) Resorcinol derivatives
BR112013031121B1 (pt) Composto para modulação de uma quinase
WO2022095910A1 (zh) 用作激酶抑制剂的化合物及其应用
AU2004237130A1 (en) Positive modulators of nicotinic acetylcholine receptors
JP2010536807A (ja) キネシンスピンドルタンパク質(eg5)の阻害剤としてのインドロピリジン
BR112016018371B1 (pt) Derivados de indolona substituídos com pirrol, composição os compreendendo e uso dos mesmos
WO2017049992A1 (zh) Egfr激酶抑制剂及其制备方法和应用
JP3068875B2 (ja) アミン誘導体、その製造方法、心臓脈管疾患および症状を治療するための医薬